About 20-40% of adults with symptoms of COPD – but not the disease itself – use these types of long-lasting inhalers.

Study reveals the pervasiveness of the medical devices’ skin-color bias.

Findings could eventually translate to therapeutics to improve outcomes from respiratory illness in people.

Highlights from the American Thoracic Society 2022 Conference from Michigan Medicine researchers.

The findings provide promise of targeted treatment for patients with the disease.

Research uncovers racial bias in oxygen readings during the pandemic, even amongst patients needing ECMO.